Snail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cells

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 5, 2015, Pages 7388-7393

  Wang, Yu Lou ^a   Zhao, Xue Min ^a   Shuai, Zhi Feng ^a   Li, Chun Yan ^a   Bai, Qing Yang ^a   Yu, Xiu Wen ^a   Wen, Qiu Ting ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Epithelium mesenchymal transformation; Molecular mechanism; Ovarian cancer; Snail

Indexed keywords

BETA CATENIN; FIBRONECTIN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADULT; ARTICLE; CANCER CELL; CANCER TISSUE; CELL INVASION ASSAY; CELL LEVEL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

GASTROPODA;

EID: 84936995048     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. [1] Scarlett UK, Rutkowski MR, Rauwerdink AM, Fields J, Escovar-Fadul X, Baird J, Cubillos-Ruiz JR, Jacobs AC, Gonzalez JL, Weaver J, Fiering S and Conejo-Garcia JR. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med 2012; 209: 495-506.
2. [2] Ye H, Karim AA and Loh XJ. Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: a review. Mater Sci Eng C Mater Biol Appl 2014; 45: 609-619.
3. [3] Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
4. [4] Chen ZS, Ling DJ, Zhang YD, Feng JX, Zhang XY and Shi TS. Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving beta-catenin/E-cadherin complex degradation. Mol Med Rep 2015; 11: 1851-1858.
5. [5] Stewart CJ and McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 2013; 62: 31-43.
6. [6] Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
7. [7] Xu D, Liang C and He J. Large malignant ovarian tumors during pregnancy: two cases. Onco Targets Ther 2014; 7: 2121-2125.
8. [8] Du F, Wu X, Liu Y, Wang T, Qi X, Mao Y, Jiang L, Zhu Y, Chen Y, Zhu R, Han X, Jin J, Ma X and Hua D. Acquisition of paclitaxel resistance via PI3Kdependent epithelialmesenchymal transition in A2780 human ovarian cancer cells. Oncol Rep 2013; 30: 1113-1118.
9. [9] Lili LN, Matyunina LV, Walker LD, Wells SL, Benigno BB and McDonald JF. Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis. J Ovarian Res 2013; 6: 49.
10. [10] Hay ED. The extracellular matrix in development and regeneration. An interview with Elizabeth D. Hay. Int J Dev Biol 2004; 48: 687-694.
11. [11] Acloque H, Thiery JP and Nieto MA. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 2008; 9: 322-326.
12. [12] Radisky DC. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-4326.
13. [13] Shi JW, Liu W, Zhang TT, Wang SC, Lin XL, Li J, Jia JS, Sheng HF, Yao ZF, Zhao WT, Zhao ZL, Xie RY, Yang S, Gao F, Fan QR, Zhang MY, Yue M, Yuan J, Gu WW, Yao KT and Xiao D. The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation. Cell Cycle 2013; 12: 1119-1127.
14. [14] Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D and Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006; 9: 261-272.
15. [15] Yilmaz M and Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
16. [16] Jaaback K, Johnson N and Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2011; CD005340.
17. [17] Pfisterer J, Harter P, Canzler U, Richter B, Jackisch C, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Bois A, Committee AGOO and Group AGOOCS. The role of surgery in recurrent ovarian cancer. Int J Gynecol Cancer 2005; 15 Suppl 3: 195-198.
18. [18] Kumar S, Das A and Sen S. Extracellular matrix density promotes EMT by weakening cell-cell adhesions. Mol Biosyst 2014; 10: 838-850.
19. [19] Lu WH, Wang G, Li Y, Li S, Song XY, Wang XY, Chuai M, Lee KK, Cao L and Yang X. Autophagy functions on EMT in gastrulation of avian embryo. Cell Cycle 2014; 13: 2752-2764.
20. [20] Palma-Nicolas JP and Lopez-Colome AM. Thrombin induces slug-mediated E-cadherin transcriptional repression and the parallel up-regulation of N-cadherin by a transcription-independent mechanism in RPE cells. J Cell Physiol 2013; 228: 581-589.